Evidence map›Paper›PMID 33073012›Full record

ArticleInternational journal of neonatal screening2020

Benzene Derivatives from Ink Lead to False Positive Results in Neonatal Hyperphenylalaninemia Screening with Ninhydrin Fluorometric Method.

Shuren Feng, Joanne Mei, Lu Yang, Ping Luo, Xiaonan Wang, Yuan Wang, Jingyi Yao, Lan Cui, Lei Pan, Zefang Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of neonatal screening, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Shuren FengTianjin Women's and Children's Health Centre, Tianjin 300070, China; yaojingyi82@126.com (J.Y.); cuilan68@126.com (L.C.); panlei2121@126.com (L.P.); xinli66@126.com (L.X.).ORCID 0000-0003-1619-3436
Joanne MeiNewborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA; jvm0@cdc.gov.
Lu YangDepartment of Biology, College of Life Sciences, Tianjin University, Tianjin 300072, China; yanglululu@tju.edu.cn (L.Y.); zefangwang@tju.edu.cn (Z.W.).
Ping LuoDepartment of Basic Medicine, Tianjin Medical College, Tianjin 300222, China; luoping62@163.com.
Xiaonan WangTianjin Medical Laboratory, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China; douding.wxn@gmail.com.
Yuan WangBinhai Genomics Institute, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China; yuanwang@genomics.cn.
Jingyi YaoTianjin Women's and Children's Health Centre, Tianjin 300070, China; yaojingyi82@126.com (J.Y.); cuilan68@126.com (L.C.); panlei2121@126.com (L.P.); xinli66@126.com (L.X.).
Lan CuiTianjin Women's and Children's Health Centre, Tianjin 300070, China; yaojingyi82@126.com (J.Y.); cuilan68@126.com (L.C.); panlei2121@126.com (L.P.); xinli66@126.com (L.X.).
Lei PanTianjin Women's and Children's Health Centre, Tianjin 300070, China; yaojingyi82@126.com (J.Y.); cuilan68@126.com (L.C.); panlei2121@126.com (L.P.); xinli66@126.com (L.X.).
Zefang WangDepartment of Biology, College of Life Sciences, Tianjin University, Tianjin 300072, China; yanglululu@tju.edu.cn (L.Y.); zefangwang@tju.edu.cn (Z.W.).
Li XinTianjin Women's and Children's Health Centre, Tianjin 300070, China; yaojingyi82@126.com (J.Y.); cuilan68@126.com (L.C.); panlei2121@126.com (L.P.); xinli66@126.com (L.X.).
Tianjin Children's Hospital · CNTianjin Medical University · CNTianjin University · CNBGI Group (China) · CNCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ninhydrin-based fluorometric quantification of phenylalanine is one of the most widely used methods for hyperphenylalaninemia (HPA) screening in neonates due to its high sensitivity, high accuracy, and low cost. Here we report an increase of false positive cases in neonatal HPA screening with this method, caused by contamination of blood specimen collection devices during the printing process. Through multiple steps of verification, the contaminants were identified from ink circles printed on the collection devices to indicate the positions and sizes of blood drops. Blood specimens from HPA-negative persons collected on these contaminated collection devices showed positive results in the fluorometric tests, but negative results in tandem mass spectroscopy (MS/MS) experiments. Contaminants on the collection devices could be extracted by 80% ethanol and showed an absorption peak around 245 nm, suggesting that these contaminants may contain benzene derivatives with similar structure to phenylalanine. High-performance liquid chromatography (HPLC) analysis of the ethanol extracts from contaminated collection devices identified two prominent peaks specifically from the devices. Methyl-2-benzoylbenzoate (MBB, CAS#606-28-0) was found as one of the major chemicals from contaminated collection devices. This report aims to remind colleagues in the field of this potential contamination and call for tighter regulation and quality control of specimen collection devices.

Indexed as

dried blood spotsfilter paperhyperphenylalaninemia (HPA), false-positiveNeonatal Screeningnewbornsninhydrin fluorometric testspecimen collection devices

Identifiers

PMID33073012
PMCPMC7422975
OpenAlexW3009613726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.